Back to News
Market Impact: 0.2
Bronstein, Gewirtz & Grossman LLC Urges ARS Pharmaceuticals Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Source: globenewswire.com
Legal & LitigationHealthcare & Biotech
Bronstein, Gewirtz & Grossman announced that a securities class-action lawsuit has been filed against ARS Pharmaceuticals (NASDAQ: SPRY) and certain officers. The announcement provides no allegations, claimed damages, class period, or financial impact details, but the litigation notice represents a potential reputational and legal overhang for the company.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.30
Ticker Sentiment
SPRY-0.80
More News
- Aker BP Q3 profit tops forecast on $870 million writedown reversal
- Kalshi, co-founders hit with criminal charges in US state of Utah
- Judge says Trump's bid to set aside California ballots would ‘wreak havoc’ on democracy
- Bausch Health raises 2026 outlook as third-quarter adjusted earnings surge 53%
- Utah criminally charges Kalshi with promoting illegal gambling
- FTC and 20 states sue Dollar General, saying it overcharged its poorest customers by millions